About 395,000 results
Open links in new tab
  1. Securities Fraud Investigation Into Novo Nordisk A/S (NVO ...

    Jul 30, 2025 · LOS ANGELES-- (BUSINESS WIRE)-- The Law Offices of Frank R. Cruz continues its investigation of Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) on behalf of …

    Missing:
    • Vandalism
    Must include:
  2. Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield

    Oct 2, 2025 · Just a little over a year into a potential $1.3 billion partnership on an experimental drug for cardiovascular and kidney diseases, the friendly handshakes at the deal table have dissolved into...

    Missing:
    • Vandalism
    Must include:
  3. Novo Nordisk Sways Jury to Reject Whistleblower’s Fraud Suit (2)

    Nov 10, 2025 · Novo Nordisk Inc. convinced a jury to reject claims that the pharmaceutical giant defrauded Washington state’s Medicaid by improperly billing the health-care program for its …

    Missing:
    • Vandalism
    Must include:
  4. Novo Nordisk reprimanded over undisclosed payments

    Jul 5, 2024 · Novo Nordisk has been publicly reprimanded by a UK industry body for failing to properly disclose £7.8mn in payments and other benefits to patient groups, healthcare bodies and journalists …

    Missing:
    • Vandalism
    Must include:
  5. Novo Nordisk Faces Legal Storm Over Misleading Projections

    Aug 4, 2025 · Novo Nordisk A/S is facing a significant legal challenge as a class action lawsuit has been filed against the company, alleging securities fraud that has impacted its shareholders.

    Missing:
    • Vandalism
    Must include:
  6. Novo Nordisk A/S Faces Class Action Over Fraud Allegations

    Mar 7, 2025 · Novo Nordisk A/S is facing a class action lawsuit concerning alleged fraud from November 2022 to December 2024, impacting many investors and shareholders.

    Missing:
    • Vandalism
    Must include:
  7. Novo Nordisk (NVO) Faces Securities Class Action After

    SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the …

    Missing:
    • Vandalism
    Must include: